Allison Aubrey
Allison Aubrey is a correspondent for NPR News, where her stories can be heard on Morning Edition and All Things Considered. She's also a contributor to the PBS NewsHour and is one of the hosts of NPR's Life Kit.
Along with her NPR science desk colleagues, Aubrey is the winner of a 2019 Gracie Award. She is the recipient of a 2018 James Beard broadcast award for her coverage of 'Food As Medicine.' Aubrey is also a 2016 winner of a James Beard Award in the category of "Best TV Segment" for a PBS/NPR collaboration. The series of stories included an investigation of the link between pesticides and the decline of bees and other pollinators, and a two-part series on food waste. In 2013, Aubrey won a Gracie Award with her colleagues on The Salt, NPR's food vertical. They also won a 2012 James Beard Award for best food blog. In 2009, Aubrey was awarded the American Society for Nutrition's Media Award for her reporting on food and nutrition. She was honored with the 2006 National Press Club Award for Consumer Journalism in radio and earned a 2005 Medical Evidence Fellowship by the Massachusetts Institute of Technology and the Knight Foundation. In 2009-2010, she was a Kaiser Media Fellow.
Joining NPR in 2003 as a general assignment reporter, Aubrey spent five years covering environmental policy, as well as contributing to coverage of Washington, D.C., for NPR's National Desk. She also hosted NPR's Tiny Desk Kitchen video series.
Before coming to NPR, Aubrey was a reporter for the PBS NewsHour and a producer for C-SPAN's Presidential election coverage.
Aubrey received her Bachelor of Arts degree from Denison University in Granville, Ohio, and a Master of Arts degree from Georgetown University in Washington, D.C.
-
The omicron variant has been detected in about one-third of U.S. states, while the delta variant infects 100,000 people a day. Officials urge people to get vaccinated and boosted.
-
New York is now among the several states where the new coronavirus strain has been detected. As the omicron variant spreads, the Biden administration announces new steps to slow COVID.
-
Concerns about omicron are growing after the head of Moderna expressed doubt about vaccines' effectiveness against the new coronavirus variant. Some scientists are more optimistic, though.
-
Scientists are collecting more information about the new variant of concern, omicron, and investigating whether existing COVID-19 vaccines offer adequate protection.
-
There are cases of this new coronavirus variant reported in several countries. How much protection can fully vaccinated people expect to have?
-
Millions of Americans are planning to travel this week and gather inside for Thanksgiving. At the same time, COVID-19 cases are rebounding. We have tips for keeping COVID out while inviting guests in.
-
Intergenerational indoor gatherings, a.k.a, Thanksgiving dinner, still pose a COVID risk to older adults and the immunocompromised. Here's how to keep everyone safe. -
CDC Director Rochelle Walensky has green-lighted the recommendation that boosters shots be made available to everyone 18 and older. A CDC advisory committee voted in favor of the recommendation prior.
-
Physicians weigh in on what you need to know about the safety and efficacy of the vaccine, and how to think about the risks and benefits of vaccinating your kid
-
The CDC this week will weigh in on Pfizer's COVID-19 vaccine for children ages 5 to 11. If final approval is given, vaccines for this age group could be available within a few days.
